Page 136 - FINAL PROGRAM

P-134 Care management of patient with early recurrent miscarriages: Embryo transfer strategy
L. Delaroche (France)
P-135 Combined rst trimester risk assessment for trisomy 21 in women with recurrent pregnancy loss (RPL)
K. Husby (Denmark)
P-136 Early onset gestational diabetes (GD) as the cause for recurrent spontaneous miscarriages (RSA): RSA, pregestational metformin treatment and pregnancy outcome
S. Fill Malfertheiner (Germany)
P-137 Molecular karyotyping of products of conception – evaluation of performance and capacity
L. Volozonoka (Latvia)
P-138 Biochemical pregnancy loss is unrelated to embryo stage of development and euploidy at transfer: evidences from 2452 warming cycles
A. Vaiarelli (Italy)
P-139 Role of G-CSF treatment in recurrent pregnancy loss in TREGblood levels and expression of FOXP3, VEGF, VEGF-R2 and C-KIT in rst trimester pregnancy specimens
M. Sbracia (Italy)
P-140 Paternal in uence of sperm transcripts and DNA damage in recurrent implantation failure
V. Dhawan (India)
P-141 Guideline-based quality indicators in Early Pregnancy Assessment Units
M. van den Berg (The Netherlands)
P-142 Maternal & perinatal outcome of pregnancies threatening to miscarry
S. Agrawal (India)
132